Back to search results
NCT05509608

Evaluating a New Sensor That Measures the Health of the Retina in Normally-sighted Subjects

Enrolling by Invitation
EARLY_PHASE1Ages 18+Interventional
RetMap, Inc
~90 participants
Updated 2025-11-14 on ClinicalTrials.gov
What's tested:RM ElectrodeERG Jet Electrode

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Arm1: ERG signal quality, including peak amplitudes, noise levels, and signal to noise ratios.
Measured over Up to 24 weeks
+1 more outcome measured

Conditions

Electrode Site Reaction

Explore related trials

Normal vision

Where it's being run

2 sites across 1 states
Illinois2

Study leadership

  • Robert Hyde, MD/PhD · PRINCIPAL_INVESTIGATOR · UIC Department of Ophthalmology & Visual Sciences
  • Michael Chaglasian, OD · PRINCIPAL_INVESTIGATOR · Illinois College of Optometry

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Persons 18 and over.

Exclusion

Pregnant woman
Individuals with existing diagnosis for any retinal disease, ocular surgery (including refractive surgery such as Lasik) within the past six months, corneal ulcers, or any noticeable ocular irritation on the study day.
Non-English speaking persons may not enroll.
Persons who may respond negatively to flashing lights in the eye will be excluded, or excused from the study if enrolled and the negative response is revealed during the study.
No vulnerable populations are expected to enroll.

What this trial measures

  • Arm1: ERG signal quality, including peak amplitudes, noise levels, and signal to noise ratios.Up to 24 weeks

    Signals recorded from both contact lens electrode will be evaluated for a-wave and b-wave peak amplitudes, signal power, noise power and signal-to-noise ratios.

  • Arm 2: Ocular irritation using clinical grading scalesUp to 24 weeks

    Slit-lamp examination and standard clinical grading scales for bulbar redness, limbal redness, tarsal redness, and corneal staining (fluorescein).